Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy

Research output: Contribution to journalLetterResearchpeer-review

Standard

Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy. / Kyvsgaard, Emil R.; Riley, Caroline; Clausen, Michael Roost; Harsløf, Mads; Heftdal, Line Dam; Niemann, Carsten U.; Grønbæk, Kirsten; Hutchings, Martin; Husby, Simon.

In: British Journal of Haematology, Vol. 204, No. 1, 2024, p. 356-360.

Research output: Contribution to journalLetterResearchpeer-review

Harvard

Kyvsgaard, ER, Riley, C, Clausen, MR, Harsløf, M, Heftdal, LD, Niemann, CU, Grønbæk, K, Hutchings, M & Husby, S 2024, 'Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy', British Journal of Haematology, vol. 204, no. 1, pp. 356-360. https://doi.org/10.1111/bjh.19156

APA

Kyvsgaard, E. R., Riley, C., Clausen, M. R., Harsløf, M., Heftdal, L. D., Niemann, C. U., Grønbæk, K., Hutchings, M., & Husby, S. (2024). Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy. British Journal of Haematology, 204(1), 356-360. https://doi.org/10.1111/bjh.19156

Vancouver

Kyvsgaard ER, Riley C, Clausen MR, Harsløf M, Heftdal LD, Niemann CU et al. Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy. British Journal of Haematology. 2024;204(1):356-360. https://doi.org/10.1111/bjh.19156

Author

Kyvsgaard, Emil R. ; Riley, Caroline ; Clausen, Michael Roost ; Harsløf, Mads ; Heftdal, Line Dam ; Niemann, Carsten U. ; Grønbæk, Kirsten ; Hutchings, Martin ; Husby, Simon. / Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy. In: British Journal of Haematology. 2024 ; Vol. 204, No. 1. pp. 356-360.

Bibtex

@article{45b9fa0ca9314ab496087e9640a900bb,
title = "Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy",
author = "Kyvsgaard, {Emil R.} and Caroline Riley and Clausen, {Michael Roost} and Mads Harsl{\o}f and Heftdal, {Line Dam} and Niemann, {Carsten U.} and Kirsten Gr{\o}nb{\ae}k and Martin Hutchings and Simon Husby",
note = "Funding Information: This study was conducted with funding from {\textquoteleft}Rigshospitalets Research Foundation{\textquoteright}, {\textquoteleft}Aase og Ejnar Danielsens Foundation{\textquoteright} and {\textquoteleft}Frk Amalie J{\o}rgensens Memorial Scholarship{\textquoteright}. ",
year = "2024",
doi = "10.1111/bjh.19156",
language = "English",
volume = "204",
pages = "356--360",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy

AU - Kyvsgaard, Emil R.

AU - Riley, Caroline

AU - Clausen, Michael Roost

AU - Harsløf, Mads

AU - Heftdal, Line Dam

AU - Niemann, Carsten U.

AU - Grønbæk, Kirsten

AU - Hutchings, Martin

AU - Husby, Simon

N1 - Funding Information: This study was conducted with funding from ‘Rigshospitalets Research Foundation’, ‘Aase og Ejnar Danielsens Foundation’ and ‘Frk Amalie Jørgensens Memorial Scholarship’.

PY - 2024

Y1 - 2024

U2 - 10.1111/bjh.19156

DO - 10.1111/bjh.19156

M3 - Letter

C2 - 37830381

AN - SCOPUS:85174072168

VL - 204

SP - 356

EP - 360

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -

ID: 371689449